Misonix Revenue and Competitors

Farmingdale, NY USA

Location

$55M

Total Funding

Estimated Revenue & Valuation

  • Misonix's estimated annual revenue is currently $22.1M per year.(i)
  • Misonix received $8.0M in venture funding in January 2007.
  • Misonix's estimated revenue per employee is $251,000
  • Misonix's total funding is $55M.

Employee Data

  • Misonix has 88 Employees.(i)
  • Misonix grew their employee count by -15% last year.

Misonix's People

NameTitleEmail/Phone
1
Director Sales Operations and AnalyticsReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Director Operations and Supply ChainReveal Email/Phone
4
Manager Medical Affiars Promoted from Territory Manager 2018Reveal Email/Phone
5
Reimbursement ManagerReveal Email/Phone
6
Associate Territory ManagerReveal Email/Phone
7
Regional Sales Manager - Mid AtlanticReveal Email/Phone
8
Clinical Application SpecialistReveal Email/Phone
9
RMA coordinatorReveal Email/Phone
10
Product Service SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$160M8004%$323.5MN/A
#2
$9.3M3712%N/AN/A
#3
$36.4M1452%N/AN/A
#4
$7M280%N/AN/A
#5
$1M4-88%N/AN/A
#6
$7.5M21-9%$6.5MN/A
#7
$6M244%N/AN/A
#8
$13.1M524%N/AN/A
#9
$17.1M68-17%N/AN/A
#10
$27.9M1114%N/AN/A
Add Company

What Is Misonix?

Transforming patients lives with better products that make a difference. Because better matters. Misonix, Inc. specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Our portfolio of products are all based upon the unique properties of ultrasound and its ability to differentiate hard and soft tissue for different clinical requirements. A fast growing global business, Misonix, Inc. operates in over 45 countries and is a recognized leader in advanced surgical tools offering unprecedented safety, speed, and precision. Our patented, portfolio of products are all based upon the unique properties of ultrasound and its ability to differentiate hard and soft tissue for different clinical requirements. Additional information is available on the Company's Web site at www.misonix.com.

keywords:Biotechnology,Cleantech,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals,Wind Power

$55M

Total Funding

88

Number of Employees

$22.1M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Misonix News

2022-04-17 - Global Monopolar Soft Tissue Dissection Market 2022-2028 ...

... Soft Tissue Dissection Market 2022-2028 Regional Analysis, Types, and Applications – Top Key Players as J & J (Ethicon), Medtronic, Olympus, Misonix.

2022-04-17 - Global Disposable Soft Tissue Dissection Device Market 2022 ...

Medtronic; Olympus; Misonix; Applied Medical; Söring GmbH. The Global Market Has Been Segmented Geographically: North America (United States,...

2022-04-17 - Global Ultrasound Surgical Device Market 2022 Industry ...

The significant players shrouded in the market report are: J & J (Ethicon); Medtronic; Olympus; Misonix; Applied Medical; Söring GmbH. ACCESS...

2010-01-12 - Misonix extends reach in South America

Misonix Inc. (NASQ:MSON) struck a deal to sell its SonaStar and BoneScalpel surgical tools in Chile. Officials with Farmingdale, N.Y.-based Misonix said the new distribution agreement with Neuromed Chile SA coincides with a renewed focus by the ultrasound device manufacturer on the Latin Americ ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.8M8910%N/A
#2
$9.2M922%N/A
#3
$23.3M93-8%N/A
#4
$24.1M9510%N/A
#5
$33.7M102-6%N/A

Misonix Funding

DateAmountRoundLead InvestorsReference
2007-01-04$8.0MUndisclosedWells Fargo BankArticle